LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP)
Stock · NASDAQ · Health Care
$22.18as of 10/16/2026
Price chart
Active signals
LFMDP Signal Track Record
How signals performed across all stocks →What LFMDP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 18 | +3.7% | 89% | October 2, 2026 |
| Bollinger Band Breakout | 20 | +1.6% | 60% | March 30, 2026 |
| 200-Day Moving Average TouchActive now | 7 | +1.9% | 71% | October 2, 2026 |
| Any 20-session window (baseline) | +0.9% | 62% |
Computed by MarketWall from daily closing prices since July 21, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LFMDP
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss…
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 347
- Website
- lifemd.com/
Fundamentals
- 1-day range
- Market cap
- $1.12B
- P/E (trailing)
- 589.89
- P/E (forward)
- —
- EPS (trailing)
- $0.01
- Dividend yield
- —
- Beta
- 2.10
- Avg. volume
- 1.6K
- Ex-dividend date
- October 2, 2026
- Dividend pay date
- October 15, 2026
LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock Competitors
Chosen by industry and closest market cap.
- LFMDPLifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock$22.18▲ 0.81%Market cap $1.12BP/E 589.89$2.36$6.53
- OMDAOmada Health Inc. Common Stock$17.63▼ 5.57%Market cap $1.16BP/E 265.49$10.28$26.92
- USPHU.S. Physical Therapy Inc. Common Stock$85.71▼ 0.31%Market cap $1.16BP/E 39.50$58.19$93.5
- TDOCTeladoc Health Inc. Common Stock$5.67▼ 5.03%Market cap $1.21BP/E —$4.4$9.89
- PNTGThe Pennant Group Inc. Common Stock$41.87▼ 0.95%Market cap $1.36BP/E 46.02$22.26$42.74
- AHCOAdaptHealth Corp. Common Stock$6.02▼ 5.79%Market cap $824.20MP/E —$5.21$13.43
- INNVInnovAge Holding Corp. Common Stock$8.85▼ 1.45%Market cap $1.49BP/E —$3.94$12.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LFMDP LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock | $1.12B | 589.89 | $22.18 | ▲ 0.81% | $2.36$6.53 |
| OMDA Omada Health Inc. Common Stock | $1.16B | 265.49 | $17.63 | ▼ 5.57% | $10.28$26.92 |
| USPH U.S. Physical Therapy Inc. Common Stock | $1.16B | 39.50 | $85.71 | ▼ 0.31% | $58.19$93.5 |
| TDOC Teladoc Health Inc. Common Stock | $1.21B | — | $5.67 | ▼ 5.03% | $4.4$9.89 |
| PNTG The Pennant Group Inc. Common Stock | $1.36B | 46.02 | $41.87 | ▼ 0.95% | $22.26$42.74 |
| AHCO AdaptHealth Corp. Common Stock | $824.20M | — | $6.02 | ▼ 5.79% | $5.21$13.43 |
| INNV InnovAge Holding Corp. Common Stock | $1.49B | — | $8.85 | ▼ 1.45% | $3.94$12.64 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
LifeMD Preferred Stock: AT&T Partnership and Dividend Update
LifeMD announced a partnership with AT&T to provide free healthcare perks to its customers. The company also declared a quarterly dividend on its Series A preferred stock. This new partnership aims to connect free members with paying patients, which is relevant to the company's growth strategy.
LifeMD Preferred Stock: AT&T Partnership and Dividend Update. LifeMD announced a partnership with AT&T to provide free healthcare perks to its customers. The company also declared a quarterly dividend on its Series A preferred stock. This new partnership aims to connect free members with paying patients, which is relevant to the company's growth strategy.